Course Faculty
Mucosal Imaging and Ablation of Early GI Neoplasia
June 27, 2009
Course Directors:
Michael B. Wallace, MD MPH |
Herbert C. Wolfsen, MD |
Gastroenterology & Hepatology |
Gastroenterology & Hepatology |
Professor of Medicine |
Professor of Medicine |
Mayo Clinic College of Medicine |
Mayo Clinic College of Medicine |
Course Faculty:
Michael F. Picco, MD, PhD |
Massimo Raimondo, MD |
Gastroenterology & Hepatology |
Gastroenterology & Hepatology |
Assistant Professor of Medicine |
Professor of Medicine |
Mayo Clinic College of Medicine |
Mayo Clinic College of Medicine |
Timothy A. Woodward, M.D. |
Gastroenterology & Hepatology |
Assistant Professor of Medicine |
Mayo Clinic College of Medicine |
EUS/EBUS
October 3, 2009
Course Directors:
Michael B. Wallace, MD MPH |
Jorge MS Pascual, MD |
Gastroenterology & Hepatology |
Pulmonary Medicine |
Professor of Medicine |
Assistant Professor of Medicine |
Mayo Clinic College of Medicine |
Mayo Clinic College of Medicine |
Course Faculty:
Elizabeth A. Johnson, MD |
Nolan Karstaedt, MD |
Hematology/Oncology |
Radiology |
Associate Professor of Medicine |
Assistant Professor of Medicine |
Mayo Clinic College of Medicine |
Mayo Clinic College of Medicine |
Murli Krishna, MD |
John A. Odell, MD |
Laboratory Medicine & Pathology |
Cardiothoracic Surgery & Transplantation |
Assistant Professor of Pathology |
Professor of Surgery |
Mayo Clinic College of Medicine |
Mayo Clinic College of Medicine |
Massimo Raimondo, MD |
Gastroenterology/Hepatology |
Professor of Medicine |
Mayo Clinic College of Medicine |
Faculty Disclosure
As a provider accredited by ACCME, Mayo Clinic College of
Medicine (Mayo School of CPD) must ensure balance, independence, objectivity and scientific
rigor in its educational activities. Course director(s), planning committee, faculty, and all
others who are in a position to control the content of this educational activity are required to
disclose all relevant financial relationships with any commercial interest related to the subject
matter of the educational activity. Safeguards against commercial bias have been put in
place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or
instruments discussed in their presentation. Disclosure of this information will be published
in course materials so those participants in the activity may formulate their own judgments
regarding the presentation.
|
